China National Medicines Corp Ltd
SSE:600511
Intrinsic Value
China National Medicines Co., Ltd. engages in the manufacturing and distribution of pharmaceuticals. [ Read More ]
The intrinsic value of one China National Medicines Corp Ltd stock under the Base Case scenario is 68.24 CNY. Compared to the current market price of 36.96 CNY, China National Medicines Corp Ltd is Undervalued by 46%.
Valuation Backtest
China National Medicines Corp Ltd
Run backtest to discover the historical profit from buying and selling China National Medicines Corp Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
China National Medicines Corp Ltd
Current Assets | 28.3B |
Cash & Short-Term Investments | 10.9B |
Receivables | 13.2B |
Other Current Assets | 4.2B |
Non-Current Assets | 4.2B |
Long-Term Investments | 1.9B |
PP&E | 828.9m |
Intangibles | 589.9m |
Other Non-Current Assets | 830.1m |
Current Liabilities | 13.9B |
Accounts Payable | 8.3B |
Accrued Liabilities | 386m |
Short-Term Debt | 2.9B |
Other Current Liabilities | 2.3B |
Non-Current Liabilities | 2.8B |
Long-Term Debt | 205.1m |
Other Non-Current Liabilities | 2.6B |
Earnings Waterfall
China National Medicines Corp Ltd
Revenue
|
49.7B
CNY
|
Cost of Revenue
|
-45.7B
CNY
|
Gross Profit
|
4B
CNY
|
Operating Expenses
|
-1.6B
CNY
|
Operating Income
|
2.4B
CNY
|
Other Expenses
|
-293.2m
CNY
|
Net Income
|
2.1B
CNY
|
Free Cash Flow Analysis
China National Medicines Corp Ltd
Profitability Score
Profitability Due Diligence
China National Medicines Corp Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
Score
China National Medicines Corp Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
China National Medicines Corp Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Score
China National Medicines Corp Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
China National Medicines Corp Ltd
According to Wall Street analysts, the average 1-year price target for China National Medicines Corp Ltd is 45.19 CNY with a low forecast of 41.41 CNY and a high forecast of 49.98 CNY.
Shareholder Return
Price
China National Medicines Corp Ltd
Average Annual Return | 13.94% |
Standard Deviation of Annual Returns | 44.98% |
Max Drawdown | -58% |
Market Capitalization | 27.9B CNY |
Shares Outstanding | 754 503 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
China National Medicines Co., Ltd. engages in the manufacturing and distribution of pharmaceuticals. The company is headquartered in Beijing, Beijing and currently employs 3,005 full-time employees. The company went IPO on 2002-11-27. The firm's primary products include proprietary Chinese medicines, chemical medicine preparations, chemical raw materials, antibiotics, biochemical drugs, biological products, narcotic drugs, psychotropic drugs, vaccines and health foods, among others. The firm is also involved in the production of pharmaceuticals and the provision of warehousing services through its subsidiaries.
Contact
IPO
Employees
Officers
The intrinsic value of one China National Medicines Corp Ltd stock under the Base Case scenario is 68.24 CNY.
Compared to the current market price of 36.96 CNY, China National Medicines Corp Ltd is Undervalued by 46%.